Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2024-01-19 00:00:00 ET · period of report 2024-01-19 · accession 0001209191-24-001982 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-19 | 2024-01-19 | HRTX | Christian Waage | Dir | A - Grant | $0.00 | +13.9K | 66.2K | +27% | $0 |
| D | 2024-01-19 | 2024-01-19 | HRTX | Christian Waage | Dir | A - Grant | $0.00 | +83.7K | 83.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-19 | A | A | 13,948 | $0.00 | 66,180 | D | — | — | (F1) The shares were granted as restricted stock units which vest in full on January 19, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-01-19 | A | A | 83,685 | $0.00 | 83,685 | D | $2.09 · — to 2034-01-19 | 83,685 Common Stock | (F2) The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. |